000 04012cam a2200565 a 4500
001 16020894
003 OSt
005 20150408114105.0
008 091211s2010 nyua b 001 0 eng c
010 _a 2009943283
015 _aGBB004919
_2bnb
015 _aGBB004919
_2dnb
016 7 _a101527291
_2DNLM
016 7 _a015462739
_2Uk
020 _a9781607615842 (alk. paper)
020 _a1607615843 (alk. paper)
020 _a9781607615859 (eISBN)
020 _a1607615851 (eISBN)
035 _a(OCoLC)ocn449852931
040 _aNLM
_beng
_cNLM
_dDLC
_dUKM
_dBTCTA
_dYDXCP
_dSCB
_dCUS
_dCOU
_dNTD
_dAGL
_dDEBBG
_dDLC
042 _apcc
050 0 0 _aQR187.3
_b.V326 2010
060 0 0 _aW1
_bME9616J v.626 2010
060 1 0 _aQW 800
_bV1156 2010
070 0 _aQR187.3
_b.V33 2010
082 0 0 _a616.079
_223
_bVAA
084 _aVS 9000
_2rvk
084 _aXD 3300
_2rvk
245 0 0 _aVaccine adjuvants :
_bmethods and protocols /
_cedited by Gwyn Davies.
260 _aNew York, NY :
_bHumana Press,
_cc2010.
300 _ax, 314 p. :
_bill. ;
_c26 cm.
490 1 _aSpringer protocols
490 1 _aMethods in molecular biology,
_x1064-3745 ;
_v626
504 _aIncludes bibliographical references and index.
505 0 0 _tImmunology of vaccine adjuvants /
_rC.M.S. Ribeiro and V.E.J.C. Schijns --
_tPreclinical development of AS04 /
_rN. Garçon -- Nonclinical safety assessment of vaccines and adjuvants /
_rJ.J. Wolf, C.V. Kaplanski and J.A. Lebron --
_tAluminum adjuvants: Preparation, application, dosage, and formulation with antigen /
_rE.B. Lindblad and N.E. Schønberg --
_tFreund's complete and incomplete adjuvants, preparation, and quality control standards for experimental laboratory animals use /
_rD.E.S. Stewart-Tull --
_tLiposomal adjuvants: Preparation and formulation with antigens /
_rJ. Haensler --
_tMicro/nanoparticle adjuvants: Preparation and formulation with antigens /
_rP. Malyala and M. Singh --
_tAdjuvant activity on human cells in vitro /
_rD. Wit and M. Goldman --
_tAdjuvant activity on murine and human macrophages /
_rV. Quesniaux, F. Erard and B. Ryffel --
_tIn vitro effects of adjuvants on B cells /
_rJ. Vollmer and H. Bellert --
_tNKT cell responses to glycolipid activation /
_rJ.N. Tefit, G. Davies and V. Serra --
_tTracking dendritic cells in vivo /
_rC.M. Rush and J.M. Brewer --
_tAdjuvant effects on antibody titre /
_rB. Walker and I. Feavers --
_tFunctional antibody assays / I. Feavers and B. Walker --
_tDetermining adjuvant activity on -cell function in vivo: Th cells /
_rT. Lindenstrøm, P. Andersen and E.M. Agger --
_tQuantitative multiparameter assays to measure the effect of adjuvants on human antigen-specific CD8 t-cell responses / L. Derré ... [et al.] --
_tLarge-animal model for establishing E/T ratio of adjuvants /
_rL.A.T. Hilgers --
_tDetermining the activity of mucosal adjuvants /
_rB.C. Baudner and G.D. Giudice --
_tAdjuvant activity of cytokines /
_rM.G. Tovey and C. Lallemand
650 0 _aImmunological adjuvants
_xResearch.
_918571
650 0 _aImmunological adjuvants
_xResearch
_xMethodology.
_918572
650 2 _aAdjuvants, Immunologic
_xtherapeutic use.
_918573
650 2 _aVaccines
_ximmunology.
_918574
650 7 _aAdjuvans.
_2swd
_918575
650 7 _aImpfstoff.
_2swd
_918576
700 1 _aDavies, Gwyn,
_cPh. D.
_918577
830 0 _aSpringer protocols.
_917336
830 0 _aMethods in molecular biology (Clifton, N.J.) ;
_vv. 626.
_918578
856 _uhttp://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=020299208&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
_zInhaltsverzeichnis
856 _uhttp://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=020299208&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA
_zKlappentext
906 _a7
_bcbc
_cpccadap
_d2
_eepcn
_f20
_gy-gencatlg
942 _2ddc
_cDVD
999 _c26507
_d261007